Cladribine is linked to lower risk for disability progression in patients with relapsing-remitting multiple sclerosis vs ...

Mesenchymal stem cell therapy shows promise for treating MS, but more research is needed on long-term safety and efficacy, a ...

Professor Stefano Pluchino from the University of Cambridge, who co-led the study, said: "We desperately need to develop new treatments for secondary progressive MS, and I am cautiously very excited ...

MS patients have increased risks of developing other autoimmune diseases, necessitating careful treatment planning to balance efficacy and risk. Dimethyl fumarate, anti-CD20 antibodies, and ozanimod ...

Listen to Post Therapies for Multiple Sclerosis: Exploring Treatments for MS Multiple sclerosis (MS) is a ...

Share on Pinterest A recent study reports that starting treatment at the first signs of MS symptoms could help slow disease progression. Jennifer Blount/Getty Images A recent study finds getting ...

For people living with multiple sclerosis (MS), the search for effective treatment options can feel like a never-ending journey. While disease-modifying therapies (DMTs) have improved outcomes for ...

Over time, MS treatment patterns have changed as several new DMTs have been approved; this has increased treatment options for both patients and providers. Convenience of administration, insurance ...

Professional societies of neurologists, including most prominently the American Academy of Neurology (AAN) and the European Academy of Neurology (EAN) periodically release recommendations to guide ...